Navigation Links
Breakthrough in understanding life-threatening childhood liver disease
Date:10/26/2010

Researchers at the University of Colorado School of Medicine and The Children's Hospital have taken a big step toward understanding what causes one of the most serious liver diseases in infants.

The disease is called biliary atresia, It blocks the bile ducts in young infants, through which bile, crucial for digestion, flows to the small intestine. The disease is rare it strikes in about one in 10,000 births. But it's life-threatening.

"It is fatal if not treated quickly," says Cara Mack, MD, who led the CU research.

Surgical removal of the blocked main bile duct can buy time but ultimately the treatment in the majority of cases is a liver transplant during infancy or childhood, a procedure that is both complicated and expensive.

Until now, doctors weren't sure what caused biliary atresia, which is important to know in order to develop better treatments. The CU researchers propose that an infection late in the third trimester of pregnancy or soon after birth initiates the bile duct injury.

The body fights off the infection and infants initially show no signs of a problem. But then, Mack says, the body continues to battle as if the infection still was active. The body, however, is attacking itself -- the bile ducts specifically -- not the infection. This is called an autoimmune process.

Why? Mack's research in a mouse model of the disease suggests that it may be that the bile ducts have been changed and the body's protective system senses that. Or it may be that the bile ducts give off a protein that is similar to proteins produced by the infection, launching the body's defenses into action. In these investigations, Mack and colleagues identified an immune system compound, anti-enolase antibody, that reacts to both virus and bile duct proteins. This antibody may contribute to the bile duct injury in biliary atresia.

"After a viral infection has resolved," Mack says, "the body's immune defenses turn on the bile ducts and cause continued damage."

That leads to scarring of the bile ducts, eventually blocking them so that "bile is not able to flow from the bile ducts into the intestines," says Mack, an associate professor in pediatrics with CU, who practices at The Children's Hospital in Aurora.

The discovery, published recently in the journal Gastroenterology, isn't a cure. But it is a big step, "pointing the way to new diagnostic tests and, eventually, to improved treatment options for this devastating disease," Mack says.


'/>"/>

Contact: Dan Meyers
dan.meyers@ucdenver.edu
303-724-5377
University of Colorado Denver
Source:Eurekalert

Related medicine news :

1. Popular Mechanics breakthrough awardees announced
2. University of East Anglia makes cancer breakthrough
3. European Nurse Society calls to action on breakthrough cancer pain
4. Better cholesterol drugs may follow Saint Louis University researchers breakthrough
5. Breakthrough in drug trial offers hope for heart attack patients
6. Novel nanotechnology collaboration leads to breakthrough in cancer research
7. Breakthrough news involving migraine
8. In breakthrough, nerve connections are regenerated after spinal cord injury
9. A breakthrough in tuberculosis research
10. TGen partner, PBS-Bio, makes first breakthrough drug analysis
11. Research: Major breakthrough will revolutionize the screening and treatment of genetic diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... ... Bellus Medical, a leader in medical aesthetics, recently acquired ... photodynamic cosmetics (PDC). , Allumera® is the first PDC cream specifically formulated to ... minimize the appearance of pores – all with minimal downtime and results that ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges ... for how his administration could impact the employee benefits industry. James Slotnick, AVP, ... most likely to make it through Congress. His discussion will focus on the ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies ... to help with process innovation in drug formulation and manufacturing. CoreRx offers ... state-of-the-art analytical equipment in support of their development and manufacturing goals. , ...
(Date:4/25/2017)... CA (PRWEB) , ... April 25, 2017 , ... ... the addition of predictive analytics to its patient care management module. Using this ... even before a patient has been initiated on continuous positive airway pressure (CPAP), ...
(Date:4/24/2017)... Massachusetts (PRWEB) , ... April 24, 2017 , ... ... will help busy nursing professionals advance their careers. Beginning in the fall of 2017, ... Nursing (BSN) degree in as few as 16 months and for as little as ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Global ... This report on the prostate cancer therapeutics market ... global market. Increasing prevalence of prostate cancer, launch ... in the development of new drugs & therapeutic ... cancer drug due to lesser side effects are ...
(Date:4/19/2017)... 19, 2017  New research provides evidence that an old ... to a study released today that will be presented at ... in Boston , April 22 to 28, ... of Parkinson,s disease, the oral drug levodopa has long been ... But as the disease progresses, the effects of the medication ...
(Date:4/18/2017)... April 18, 2017 Viverae ® , a ... the integration of IBM ® Watson Campaign Automation, ... targeted communications for a personalized experience. Through digital engagement, ... their health in real time. The enhanced experience drives ... to members, wherever they are in their journey to ...
Breaking Medicine Technology: